19-15644024-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000585846.1(CYP4F3):c.316A>T(p.Ile106Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000345 in 1,448,440 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I106L) has been classified as Likely benign.
Frequency
Consequence
ENST00000585846.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CYP4F3 | NM_000896.3 | c.199-1695A>T | intron_variant | ENST00000221307.13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CYP4F3 | ENST00000221307.13 | c.199-1695A>T | intron_variant | 1 | NM_000896.3 | A1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.0000127 AC: 3AN: 235374Hom.: 0 AF XY: 0.00000784 AC XY: 1AN XY: 127544
GnomAD4 exome AF: 0.00000345 AC: 5AN: 1448440Hom.: 0 Cov.: 30 AF XY: 0.00000139 AC XY: 1AN XY: 720244
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 13, 2023 | The c.316A>T (p.I106F) alteration is located in exon 3 (coding exon 2) of the CYP4F3 gene. This alteration results from a A to T substitution at nucleotide position 316, causing the isoleucine (I) at amino acid position 106 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at